Skip to content

Feasibility of Brachial Plexus Ultrasound in Evaluation of Patients With Brachial Plexus Injuries

Feasibility of Brachial Plexus Ultrasound in Evaluation of Patients With Brachial Plexus Injuries

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05810077
Enrollment
36
Registered
2023-04-12
Start date
2023-06-30
Completion date
2024-07-31
Last updated
2023-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brachial Plexus Injury

Brief summary

Evaluation of ultrasound as a diagnostic tool in assessment of patients with brachial plexus injuries before undergoing surgical exploration

Detailed description

Ultrasound of the brachial plexus is particularly good for assessing brachial plexus injuries, nerve sheath tumors,perineural fibrosis, metastasis, some inflammatory neuropathies, neuralgic amyotrophy and post traumatic sequele

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* all patients ages with brachial plexus injuries

Exclusion criteria

* patients underwent brachial plexus surgery before * patients with surgical emphysema * patients with serious skeletal malformations

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with positive ultrasound findings of brachial plexus injuries ( nerve root avulsion, nerve rupture) .Within 2 weeksNumber of patients with positive ultrasound findings of brachial plexus injuries ( nerve root avulsion, nerve rupture) among all patients with brachial plexus injuries then compare our results with operative findings (as the gold standard ) to estimate sensitivity and specificity.

Contacts

Primary ContactHager mohamed Ahmed, Master
doctorhagerlotfallah@gmail.com01093639662
Backup ContactNagham N Mahmoud, Professor
naghamnomar@gmail.com01028820041

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026